help button home button Biophys. J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Originally published as Biophys J. BioFAST on January 16, 2008.
doi:10.1529/biophysj.107.122283
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
biophysj.107.122283v1
94/9/3635    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Rigacci, S.
Right arrow Articles by Stefani, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rigacci, S.
Right arrow Articles by Stefani, M.
Biophysical Journal 94:3635-3646 (2008)
© 2008 The Biophysical Society

The (1–63) Region of the p53 Transactivation Domain Aggregates In Vitro into Cytotoxic Amyloid Assemblies

Stefania Rigacci *, Monica Bucciantini * {dagger}, Annalisa Relini {dagger} {ddagger}, Alessandra Pesce {dagger} {ddagger}, Alessandra Gliozzi {dagger} {ddagger}, Andrea Berti * {dagger} and Massimo Stefani * {dagger}

* Department of Biochemical Sciences and {dagger} Research Centre on the Molecular Basis of Neurodegeneration, University of Florence, 50134 Florence, Italy; and {ddagger} Department of Physics, University of Genoa, I-16146 Genoa, Italy

Correspondence: Address correspondence to: Stefania Rigacci and Monica Bucciantini, Department of Biochemical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy. Tel.: 39-055-4598302; Fax: 39-055-4598905; E-mail: stefania.rigacci{at}unifi.it; monica.bucciantini{at}unifi.it.

The transcriptional regulator p53 plays an essential role in tumor suppression. Accordingly, it is found mutated, and its activity is reduced, in many human cancers. Recent reports show that some cancers are characterized by a loss of function of wild-type p53, which, in several cases, accumulates in intracellular aggregates. Although the nature of such aggregates is still unclear, recent evidence indicates that the p53 C-terminal and core domains can undergo amyloid aggregation in vitro under mild denaturing conditions, although no information is available on the largely unstructured N-terminal transactivation domain. We therefore decided to investigate the amyloid propensity of the acidic unfolded 1–63 fragment of the transactivation domain, cloned, expressed, and purified from a bacterial strain. Here we show that, when exposed to acidic pH, the 1–63 fragment forms thioflavine T-positive aggregates whose amyloid nature was confirmed by Fourier transform infrared spectroscopy analysis, atomic force microscopy, and x-ray diffraction. These aggregates were shown to be cytotoxic to human SH-SY5Y cells by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide reduction, lactate dehydrogenase release, and caspase-3 activity assays. These results add new significant details to the picture describing the propensity of single domains of p53 to aggregate, further suggesting that, under suitable destabilizing conditions, the whole protein may aggregate into amyloid assemblies in vivo.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Biophysical Society.